A vertical stack of three evenly spaced horizontal lines.
The words "Business Insider"
The word "Markets Insider".
My Watchlist
Markets
Stocks
Indices
Commodities
Cryptocurrencies
Currencies
ETFs
News
An icon in the shape of a calendar.
Economic
Earnings
A magnifying glass. It indicates, "Click to perform a search".
The word "Markets Insider".
Two crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification.
The word Markets
Bonds
Funds
Pre-Market
Market Movers
Dow Jones Live
Your Portfolio
The word Stocks
Stocks Finder
Market Movers
Index Constituents
Earnings Calendar
Dividends
The word Indices
Market Movers
Index Constituents
Dow Jones Live
S&P 500 Live
Nasdaq Live
World Map
The word Commodities
News
Commodities Live
Gold
Oil
Copper
The word Cryptocurrencies
Bitcoin
Ethereum
Cryptocurrencies Live
The word Currencies
News
Currencies Live
Currency Converter
EUR/USD
GBP/USD
US Dollar Index
The word ETFs
News
ETF Finder
ETF Issuers
The word News
My Watchlist
My Watchlist
The letter F.
A stylized bird with an open mouth, tweeting.
The word "in".
A play button in the shape of a television screen.
A stylized camera.
The words "Business Insider"
© 2024
Insider Inc. and
finanzen.net
GmbH (Imprint). All rights reserved.
Registration on or use of this site constitutes acceptance of our
Terms of Service
and
Privacy Policy.
Disclaimer
Accessibility
Commerce Policy
Advertising Policies
Made in NYC
Stock quotes by
finanzen.net
Home
Stocks
Johnson & Johnson-stock
News for Johnson & Johnson
News for Johnson & Johnson
Seeking Alpha
13h
Here are Big Pharma’s leading blockbuster makers
InvestorPlace
2d
7 Consumer Staples Stocks to Buy at a 52-Week Low in July
InvestorPlace
2d
3 Blue-Chip Stocks to Buy for Christmas in July
Seeking Alpha
2d
Dividend Roundup: Goldman Sachs, Johnson & Johnson, Qualcomm, Caterpillar, and more
Seeking Alpha
3d
J&J ends work on Addex epilepsy drug candidate ADX71149: report
Benzinga
3d
Johnson & Johnson Prioritizes Sustainable Growth in M&A Amid Sector Diversification, Says Analyst
Benzinga
3d
These Analysts Revise Their Forecasts On Johnson & Johnson After Q2 Results
InvestorPlace
3d
3 Dividend Stocks That Demand Investor Attention
Seeking Alpha
3d
Med-tech and healthcare stocks with upside during 2Q earnings - Baird
InvestorPlace
3d
3 Blue-Chip Stocks to Buy If the Dow Crashes
Benzinga
3d
Microsoft To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Thursday
TipRanks
3d
Maintaining Hold on Johnson & Johnson: A Balanced View Amidst Q2 Results and Future Challenges
TipRanks
3d
Johnson & Johnson (JNJ) Receives a Buy from Argus Research
TipRanks
3d
Balanced Outlook for Johnson & Johnson: Hold Rating Amidst Growth and Challenges
TipRanks
4d
Johnson & Johnson (JNJ) Gets a Buy from RBC Capital
TipRanks
4d
Maintaining Hold on Johnson & Johnson: Balancing MedTech Challenges with Pharmaceutical Strengths and Steady Long-Term Growth
TipRanks
4d
Positive Outlook: Joanne Wuensch Recommends ‘Buy’ on Johnson & Johnson Amid Strong Q2 Performance and Promising Growth Prospects
TipRanks
4d
Buy Rating Affirmed for Johnson & Johnson on Robust Q2 Performance and Strategic Growth Outlook
Benzinga
4d
Nasdaq 100 Suffers Worst Day In 11 Months As Chipmakers Tumble On China Curbs; Magnificent 7 Wipe Out $500B : What's Driving Markets Wednesday?
TipRanks
4d
Watchful Optimism: Balancing Johnson & Johnson’s Innovative Success and MedTech Challenges
Seeking Alpha
4d
Big pharma rally after J&J earnings
TipRanks
4d
Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Elevance Health (ELV) and Johnson & Johnson (JNJ)
Seeking Alpha
4d
J&J beats in Q2 as pharma segment outperforms
RTTNews
4d
Johnson & Johnson Q2 Adj. EPS Beats View, Cuts FY24 Earnings Forecast
Seeking Alpha
4d
4 stocks to watch on Wednesday: JNJ, UAL and more
RTTNews
4d
Johnson & Johnson Q2 Profit Decreases, But Beats Estimates
InvestorPlace
5d
3 Dividend Stocks With 3%+ Yields to Upgrade Your Annual Income
Seeking Alpha
5d
Johnson & Johnson in charts: Innovative Medicine, MedTech and total U.S. sales highest in Q2
Seeking Alpha
5d
Earnings Summary: Johnson & Johnson tops consensus in Q2, updates FY2024 outlook
Seeking Alpha
5d
Johnson & Johnson declares $1.24 dividend
Seeking Alpha
5d
Johnson & Johnson Non-GAAP EPS of $2.82 beats by $0.12, revenue of $22.4B beats by $60M
RTTNews
5d
ORIC Enters Into Clinical Trial Collaboration And Supply Agreements With Bayer and J&J; Stock Up
Seeking Alpha
5d
ORIC collaborates with Bayer, J&J on prostate cancer study
Benzinga
5d
Johnson & Johnson Q2 Earnings Preview: Can New Drugs Lift Sagging Stock?
InvestorPlace
5d
3 Safe Dividend Kings to Recession-Proof Your Portfolio
Benzinga
5d
Johnson & Johnson: Bullish Charts Signal Strong Setup Before Q2 Earnings
Seeking Alpha
5d
Notable earnings before Wednesday's open
Markets Insider Automation
5d
Johnson Johnson earnings: here's what Wall Street expects
Seeking Alpha
5d
Johnson & Johnson Q2 Preview: Focus on SWAV deal implications and guidance
InvestorPlace
6d
If You Can Only Buy One Dow Stock in July, It Better Be One of These 3 Names
TipRanks
6d
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Envista Holdings (NVST), Johnson & Johnson (JNJ) and CVS Health (CVS)
Seeking Alpha
6d
Genmab upgraded at RBC on valuation
TipRanks
7d
Hold Rating Maintained Amid Johnson & Johnson Acquisition and Foreign Exchange Concerns
Seeking Alpha
7d
Earnings week ahead: BAC, GS, JNJ, TSM, UNH, ABT, UAL, NFLX, AXP and more
Seeking Alpha
8d
Morgan Stanley sees $180B patent cliff, $380B deal capacity fueling biopharma M&A
Seeking Alpha
8d
Financial stocks deliver profits in Q2 amid rebound in investments - Earnings Scorecard
Seeking Alpha
9d
Catalyst Watch: Netflix, Taiwan Semi, Amazon, and HashiCorp are in the spotlight
Seeking Alpha
9d
Legend Biotech surges amid takeover speculation (update)
TipRanks
10d
Stifel Nicolaus Remains a Hold on Johnson & Johnson (JNJ)
InvestorPlace
10d
3 Essential Stocks for Building a Recession-Proof Portfolio
Page
Page
Page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
Page
Page
Johnson & Johnson Peer Group News
12/15/20
Moderna slides 7% even as FDA confirms vaccine's effectiveness and safety
12/11/20
Pfizer falls 2% as FDA nears final authorization of its COVID-19 vaccine
12/01/20
S&P 500 and Nasdaq close at record highs as investors bet that a vaccine will drive an economic rebound
11/30/20
Novavax climbs 11% after announcing data from UK vaccine trial are expected in early 2021
11/18/20
Pfizer and BioNTech climb as 95% vaccine effectiveness tees up application for FDA approval